Europe Rare Disease Genetic Testing Market Size & Outlook
Europe rare disease genetic testing market, 2016-2028 (US$M)
Related Markets
Europe rare disease genetic testing market highlights
- The Europe rare disease genetic testing market generated a revenue of USD 208.0 million in 2020.
- The market is expected to grow at a CAGR of 9.3% from 2021 to 2028.
- In terms of segment, immunological disorders was the largest revenue generating disease type in 2020.
- Cardiovascular Disorders is the most lucrative disease type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2021 to 2028.
Europe data book summary
| Market revenue in 2020 | USD 208.0 million |
| Market revenue in 2028 | USD 422.8 million |
| Growth rate | 9.3% (CAGR from 2020 to 2028) |
| Largest segment | Immunological disorders |
| Fastest growing segment | Cardiovascular Disorders |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine & Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disease |
| Key market players worldwide | Quest Diagnostics Inc, Centogene NV Ordinary Shares, Invitae Corp, Eurofins Scientific SE, PerkinElmer, Macrogenics Inc, Fulgent Genetics Inc, Myriad Genetics Inc, Labcorp Holdings Inc, OPKO Health Inc, 3billion, ARUP Laboratories, Strand Life Sciences, Ambry Genetics, REALM IDx, Inc., Baylor Genetics, Health Network Laboratories, PreventionGenetics, Biora Therapeutics, CooperSurgical, Artemis DNA |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.7% of the global rare disease genetic testing market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 310.8 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rare Disease Genetic Testing Market Scope
Rare Disease Genetic Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe rare disease genetic testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rare disease genetic testing market will help companies and investors design strategic landscapes.
Immunological disorders was the largest segment with a revenue share of 13.32% in 2020. Horizon Databook has segmented the Europe rare disease genetic testing market based on neurological disorders, immunological disorders, hematology diseases, endocrine & metabolism diseases, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology disease covering the revenue growth of each sub-segment from 2016 to 2028.
Effective regulatory plans to combat rare disease across Europe is one of the key drivers of Europe market. Furthermore, presence of a substantial number of registries that provides data and relevant information pertaining to rare disease has aided in the revenue growth over the past years.
In addition, ongoing conferences in the region to raise awareness for rare and ultra-rare conditions is anticipated to boost adoption of diagnostic kits and services in the region. For instance, Ergomed and PSR Orphan Experts, with its offices in the UK, Germany, the Netherlands, Poland, and other countries.
Reasons to subscribe to Europe rare disease genetic testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe rare disease genetic testing market databook
-
Our clientele includes a mix of rare disease genetic testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe rare disease genetic testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe rare disease genetic testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Europe rare disease genetic testing market size, by country, 2016-2028 (US$M)
Europe Rare Disease Genetic Testing Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
